Udecol Tablet (Ursodeoxycholic Acid)

Adult dose

1. Cholesterol Gallstones: 200-250 mg orally three times daily. 2. Primary Biliary Cirrhosis: 200-300 mg orally three times daily with meals. 3. Chronic Hepatitis C: 200 mg orally three times daily. If necessary, it can be increased to 300 mg orally three times daily.

This medication should not be taken by individuals who are allergic to certain ingredients. Patients with severe bile duct obstruction should not use this medication as it may aggravate their symptoms. Patients with acute liver inflammation should also avoid taking this medication. Those with calcified gallstones or non-functional gallbladders should not take this medication either. Patients with acute cholecystitis, women who are pregnant or may become pregnant, and nursing mothers should also avoid using this medication. Children and patients with kidney disease, patients with acute gastric or duodenal ulcers, and patients with inflammatory bowel diseases like Crohn's disease should not take this medication. This medication contains lactose, so individuals with certain genetic metabolic disorders should not take it. During the course of this medication, it should not be taken with oral diabetes medications, some antacids, cholesterol-lowering medications, and any drugs that may cause liver damage. Patients with severe pancreatic disease or bile duct stones should consult a doctor or pharmacist before taking this medication. Patients with variceal bleeding, hepatic encephalopathy, ascites, and those who may require urgent liver transplantation should consult a specialist before taking this medication. If gastrointestinal symptoms such as diarrhea, vomiting, loss of appetite, or abdominal pain occur, or if allergic reactions such as itching or skin rash appear, the medication should be stopped immediately and a specialist consulted. If symptoms of interstitial pneumonia such as fever, cough, or shortness of breath occur, the medication must be discontinued immediately and medical attention should be sought. If other unusual symptoms such as generalized malaise, dizziness, or increased liver enzymes occur, the medication should be stopped and a specialist consulted. In patients with cirrhosis who have severe jaundice, this medication should be used cautiously, and regular liver function tests should be performed during treatment. The risk of severe adverse reactions with overdose is low, but liver function testing may be warranted if necessary. Elderly patients may require dose adjustments considering diminished physical function. Dissolution therapy for gallstones usually takes 6 months to 2 years, so treatment effects should be verified through imaging every 6 months, and if gallstones have not decreased after one year, treatment should be discontinued. This medication should be stored out of reach of children and kept sealed in its original container. Care should be taken when transferring to other containers as this may lead to misuse or degradation of quality.

Serious side effects

Fever, cough, shortness of breath (interstitial pneumonia), elevated serum bilirubin levels (jaundice)

Mild side effects

• Diarrhea
• loose stools
• nausea
• vomiting
• loss of appetite
• epigastric pain
• abdominal pain
• constipation
• heartburn
• gastrointestinal discomfort

This medication can be sensitive to air and moisture, so it should be stored in a sealed container. Additionally, it is important to store it at a temperature between 1 to 30 degrees Celsius to maintain the effectiveness of the drug.

Appearance

This medicine is a white tablet.

Package unit

500 tablets/bottle, 100 tablets ((10 tablets/PTP)x10)